201 related articles for article (PubMed ID: 15718266)
1. Effects of the mutation R145G in human cardiac troponin I on the kinetics of the contraction-relaxation cycle in isolated cardiac myofibrils.
Kruger M; Zittrich S; Redwood C; Blaudeck N; James J; Robbins J; Pfitzer G; Stehle R
J Physiol; 2005 Apr; 564(Pt 2):347-57. PubMed ID: 15718266
[TBL] [Abstract][Full Text] [Related]
2. Lys184 deletion in troponin I impairs relaxation kinetics and induces hypercontractility in murine cardiac myofibrils.
Iorga B; Blaudeck N; Solzin J; Neulen A; Stehle I; Lopez Davila AJ; Pfitzer G; Stehle R
Cardiovasc Res; 2008 Mar; 77(4):676-86. PubMed ID: 18096573
[TBL] [Abstract][Full Text] [Related]
3. Functional consequences of the human cardiac troponin I hypertrophic cardiomyopathy mutation R145G in transgenic mice.
Wen Y; Pinto JR; Gomes AV; Xu Y; Wang Y; Wang Y; Potter JD; Kerrick WG
J Biol Chem; 2008 Jul; 283(29):20484-94. PubMed ID: 18430738
[TBL] [Abstract][Full Text] [Related]
4. Troponin I Mutations R146G and R21C Alter Cardiac Troponin Function, Contractile Properties, and Modulation by Protein Kinase A (PKA)-mediated Phosphorylation.
Cheng Y; Rao V; Tu AY; Lindert S; Wang D; Oxenford L; McCulloch AD; McCammon JA; Regnier M
J Biol Chem; 2015 Nov; 290(46):27749-66. PubMed ID: 26391394
[TBL] [Abstract][Full Text] [Related]
5. A mutation in the N-terminus of troponin I that is associated with hypertrophic cardiomyopathy affects the Ca(2+)-sensitivity, phosphorylation kinetics and proteolytic susceptibility of troponin.
Gomes AV; Harada K; Potter JD
J Mol Cell Cardiol; 2005 Nov; 39(5):754-65. PubMed ID: 16005017
[TBL] [Abstract][Full Text] [Related]
6. Functional analysis of a troponin I (R145G) mutation associated with familial hypertrophic cardiomyopathy.
Lang R; Gomes AV; Zhao J; Housmans PR; Miller T; Potter JD
J Biol Chem; 2002 Apr; 277(14):11670-8. PubMed ID: 11801593
[TBL] [Abstract][Full Text] [Related]
7. Functional consequences of the mutations in human cardiac troponin I gene found in familial hypertrophic cardiomyopathy.
Takahashi-Yanaga F; Morimoto S; Harada K; Minakami R; Shiraishi F; Ohta M; Lu QW; Sasaguri T; Ohtsuki I
J Mol Cell Cardiol; 2001 Dec; 33(12):2095-107. PubMed ID: 11735257
[TBL] [Abstract][Full Text] [Related]
8. Kinetic mechanism of the Ca2+-dependent switch-on and switch-off of cardiac troponin in myofibrils.
Solzin J; Iorga B; Sierakowski E; Gomez Alcazar DP; Ruess DF; Kubacki T; Zittrich S; Blaudeck N; Pfitzer G; Stehle R
Biophys J; 2007 Dec; 93(11):3917-31. PubMed ID: 17704185
[TBL] [Abstract][Full Text] [Related]
9. Expression and purification of human cardiac troponin subunits and their functional incorporation into isolated cardiac mouse myofibrils.
Krüger M; Pfitzer G; Stehle R
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Mar; 786(1-2):287-96. PubMed ID: 12651025
[TBL] [Abstract][Full Text] [Related]
10. Effects of T142 phosphorylation and mutation R145G on the interaction of the inhibitory region of human cardiac troponin I with the C-domain of human cardiac troponin C.
Lindhout DA; Li MX; Schieve D; Sykes BD
Biochemistry; 2002 Jun; 41(23):7267-74. PubMed ID: 12044157
[TBL] [Abstract][Full Text] [Related]
11. The muscle-relaxing C-terminal peptide from troponin I populates a nascent helix, facilitating binding to tropomyosin with a potent therapeutic effect.
Hornos F; Feng HZ; Rizzuti B; Palomino-Schätzlein M; Wieczorek D; Neira JL; Jin JP
J Biol Chem; 2021; 296():100228. PubMed ID: 33814345
[TBL] [Abstract][Full Text] [Related]
12. Mutations in fast skeletal troponin I, troponin T, and beta-tropomyosin that cause distal arthrogryposis all increase contractile function.
Robinson P; Lipscomb S; Preston LC; Altin E; Watkins H; Ashley CC; Redwood CS
FASEB J; 2007 Mar; 21(3):896-905. PubMed ID: 17194691
[TBL] [Abstract][Full Text] [Related]
13. Myocardial contractile and metabolic properties of familial hypertrophic cardiomyopathy caused by cardiac troponin I gene mutations: a simulation study.
Wu B; Wang L; Liu Q; Luo Q
Exp Physiol; 2012 Jan; 97(1):155-69. PubMed ID: 21967901
[TBL] [Abstract][Full Text] [Related]
14. Contractility of myofibrils from the heart and diaphragm muscles measured with atomic force cantilevers: effects of heart-specific deletion of arginyl-tRNA-protein transferase.
Ribeiro PA; Ribeiro JP; Minozzo FC; Pavlov I; Leu NA; Kurosaka S; Kashina A; Rassier DE
Int J Cardiol; 2013 Oct; 168(4):3564-71. PubMed ID: 23739549
[TBL] [Abstract][Full Text] [Related]
15. The Relaxation Properties of Myofibrils Are Compromised by Amino Acids that Stabilize α-Tropomyosin.
Scellini B; Piroddi N; Matyushenko AM; Levitsky DI; Poggesi C; Lehrer SS; Tesi C
Biophys J; 2017 Jan; 112(2):376-387. PubMed ID: 28122223
[TBL] [Abstract][Full Text] [Related]
16. Green Tea Catechin Normalizes the Enhanced Ca2+ Sensitivity of Myofilaments Regulated by a Hypertrophic Cardiomyopathy-Associated Mutation in Human Cardiac Troponin I (K206I).
Warren CM; Karam CN; Wolska BM; Kobayashi T; de Tombe PP; Arteaga GM; Bos JM; Ackerman MJ; Solaro RJ
Circ Cardiovasc Genet; 2015 Dec; 8(6):765-73. PubMed ID: 26553696
[TBL] [Abstract][Full Text] [Related]
17. Deletion of the titin N2B region accelerates myofibrillar force development but does not alter relaxation kinetics.
Elhamine F; Radke MH; Pfitzer G; Granzier H; Gotthardt M; Stehle R
J Cell Sci; 2014 Sep; 127(Pt 17):3666-74. PubMed ID: 24982444
[TBL] [Abstract][Full Text] [Related]
18. The effect of variable troponin C mutation thin filament incorporation on cardiac muscle twitch contractions.
Mijailovich SM; Prodanovic M; Poggesi C; Powers JD; Davis J; Geeves MA; Regnier M
J Mol Cell Cardiol; 2021 Jun; 155():112-124. PubMed ID: 33636222
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation and mutation of human cardiac troponin I deferentially destabilize the interaction of the functional regions of troponin I with troponin C.
Li MX; Wang X; Lindhout DA; Buscemi N; Van Eyk JE; Sykes BD
Biochemistry; 2003 Dec; 42(49):14460-8. PubMed ID: 14661957
[TBL] [Abstract][Full Text] [Related]
20. The homozygous K280N troponin T mutation alters cross-bridge kinetics and energetics in human HCM.
Piroddi N; Witjas-Paalberends ER; Ferrara C; Ferrantini C; Vitale G; Scellini B; Wijnker PJM; Sequiera V; Dooijes D; Dos Remedios C; Schlossarek S; Leung MC; Messer A; Ward DG; Biggeri A; Tesi C; Carrier L; Redwood CS; Marston SB; van der Velden J; Poggesi C
J Gen Physiol; 2019 Jan; 151(1):18-29. PubMed ID: 30578328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
